Decision Resources Group

Decision Resources Inc is a consulting firm based in Yardley, PA, specializing in providing strategic guidance and data-driven insights to businesses across various industries. With a focus on market research and analysis, Decision Resources Inc assists clients in making informed decisions to drive growth and achieve their business objectives. Generated from their business information

Established in 2000, ImpactRx s physician network is a source of an intelligence capability database for assessing the impact of key pharmaceutical brand drivers on physician behavior and brand performance that also tracks the real-time promotional initiatives of the pharmaceutical industry and links this activity to the physician prescribing. ImpactRx is a privately held company. The company was one of the United States first promotion research organizations for the pharmaceutical industry. Its technology enables the company to collect daily and process timely, accurate and sensitive information on the perceptions and activities of high-volume prescribing physicians and provide pharmaceutical companies with the ability to diagnose and predict the efficiency and effectiveness of their sales and marketing initiatives. ImpactRx is headquartered in Mount Laurel, N.J.

Real Endpoints, located in Florham Park, NJ, specializes in creating access for medical innovations, leveraging decades of experience from senior leaders in payers, pharmacy benefit managers, and pharmaceuticals. The company focuses on identifying barriers to patient access and developing proprietary AI-driven solutions to address these challenges. Recognized as a leader in market access strategies, Real Endpoints offers a wide range of services, including pricing and contracting strategies, patient support services, and innovative contracting for rare and orphan therapies. Their platform, REAssist, provides real-time foundation fund information to assist Medicare patients with deductible and copay challenges, showcasing their commitment to enhancing patient access to vital treatments. Generated from the website